References
-
1
Chen W X, Lin H J, Zhang W F. et al .
Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography.
Hepatobiliary Pancreat Dis Int.
2005;
4
437-440
-
2
Jung M, Hofmann C, Kiesslich R, Brackrtz A.
Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam.
Endoscopy.
2000;
32
233-238
-
3
Leisure G S, O’Flaherty J, Green L, Jones D.
Propofol and postoperative pancreatitis.
Anesthesiology.
1996;
84
224-227
-
4
Anand K, Ramsay M A, Crippin J S.
Hepatocellular injury following the administration of propofol.
Anesthesiology.
2001;
95
1523-1524
-
5
Kluender C N, Klein R, Kohler B.
Dramatic increase in bilirubin after ERCP-pethidine as a possible cause of drug-induced hepatitis.
Z Gastroenterol.
2003;
41
1157-1160
F. J. Polo-Romero, MD
Internal Medicine Service Hospital Los Arcos
Plaza de La Molinera, 1 – 2ºE
30500 Molina de Segura
Murcia
Spain
Fax: +34-967-305019
Email: fpolo1111@yahoo.es
